Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha-adrenergic blockers.

W H Frishman1, S Charlap

  • 1Albert Einstein College of Medicine, Bronx, New York.

The Medical Clinics of North America
|March 1, 1988
PubMed
Summary
This summary is machine-generated.

Alpha-adrenergic blockers are crucial for treating hypertension and cardiovascular conditions. Selective blockade of alpha-receptor subtypes enhances drug safety and effectiveness.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AIDS and the heart: Clinicopathologic assessment.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

ACE inhibitors and the arterial wall. Introduction.

Postgraduate medicine·2009
Same author

Pathophysiology and medical management of systemic hypertension and pre-eclampsia in pregnancy.

Minerva medica·2006
Same author

Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists.

Drugs of today (Barcelona, Spain : 1998)·2003
Same author

Alcohol as a cardioprotective agent.

Heart disease (Hagerstown, Md.)·2002
Same author

Cardiopulmonary resuscitation 2000.

Heart disease (Hagerstown, Md.)·2002

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Alpha-adrenergic blockers are vital therapeutic agents.
  • They are used for hypertension and various cardiovascular disorders.

Purpose of the Study:

  • To highlight the significance of selective alpha-receptor subtype blockade.
  • To emphasize the improved safety and efficacy offered by selective blockers.

Main Methods:

  • Review of pharmacological data.
  • Analysis of clinical trial outcomes.

Main Results:

  • Selective alpha-blockers demonstrate enhanced therapeutic profiles.
  • Targeting specific alpha-receptor subtypes leads to better patient outcomes.

Conclusions:

  • Selective alpha-adrenergic blockers represent a significant advancement in cardiovascular pharmacotherapy.
  • The development of subtype-selective agents is key to optimizing treatment for hypertension and related conditions.